Curevac to report fourth quarter and full-year 2021 financial results and business updates on april 28, 2022

TÜbingen, germany and boston, ma / accesswire / april 22, 2022 / curevac n.v. (nasdaq:cvac), a biopharmaceutical company developing a new class of transformative medicines based on messenger ribonucleic acid ("mrna"), will report financial results, and provide business updates for the fourth quarter and full-year 2021 on thursday, april 28, 2022.

CVAC Ratings Summary

CVAC Quant Ranking